David P. Ryan M.D., a standing member of OIF’s Medical and Scientific Advisory Board, is Chief of Hematology/Oncology, Massachusetts General Hospital Cancer Center, the Clinical Director of the Mass General Cancer Center, and a Professor of Medicine, Harvard Medical School.
David undertook his hematology and oncology training at the combined Massachusetts General Hospital/Dana Farber Cancer Institute in 1996 in Boston, MA. In 1998, he was appointed Clinical Assistant in Medicine at the Massachusetts General Hospital, then Assistant in Medicine. The principal focus of David’s clinical research is the design and implementation of Phases I and II trials in gastrointestinal malignancies. Since 1998 he has been a member of both the Experimental Therapeutics Group and the Gastrointestinal Cancer Center where he has been the Clinical Director since 2003. In 2009, he became the Clinical Director of the MGH Cancer Center and in 2012, became Chief of the MGH Cancer Center. David’s clinical practice focuses exclusively on gastrointestinal oncology.
He graduated in medicine from Columbia College of Physicians and Surgeons, New York, NY in 1992 where he remained for his internship and medical residency. He is a member of the American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO) and the New England Cancer Society. David sits on the editorial board of Clinical Cancer Research and The Oncologist. He has published over 50 articles in peer review journals, reviews, book chapters and editorials and authored numerous abstracts.